Peptio

Peptide safety and regulatory status

What is documented about adverse effects, contamination and the legal status of peptides across the major regulatory jurisdictions.

Most compounds covered on this site are not approved medicines anywhere, which means no regulator has assessed them as safe or effective for any use in people. That is a specific, documented fact about each one, and it belongs alongside the efficacy research rather than in a disclaimer nobody reads.

This hub covers adverse event reports, product quality and contamination findings, and regulatory status by jurisdiction.

Peptides studied in this area

  • Afamelanotide

    Scenesse, Melanotan I, Melanotan-1, MT-1, CUV1647, NDP-MSH

    A synthetic alpha-MSH analogue approved as an implant for one rare light disease in adults. Melanotan I was a code name; products sold as it are not the drug.

    Human RCTApproved for a medical indicationskin hair / safety regulation
  • CJC-1295

    CJC-1295 DAC, DAC:GRF

    A synthetic analogue of growth hormone-releasing hormone. Two molecules share the name; only one was studied in people, for hormone levels.

    Human RCTDevelopment discontinuedperformance / safety regulation
  • Dihexa

    PNB-0408, N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, Hexanoyl-Tyr-Ile-Ahx-NH2, ATH-1001

    A synthetic angiotensin IV analogue with no human study found. Its mechanism paper was retracted in 2025; FDA lists it as a withdrawn compounding nomination.

    AnimalNo published human datacognition / safety regulation
  • DSIP

    delta sleep-inducing peptide, delta sleep inducing peptide, delta-sleep-inducing peptide, emideltide, emideltide acetate, DSIP peptide, WAGGDASGE, Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu

    A nine-amino-acid peptide named for an EEG effect in rabbits. Small 1980s human sleep studies were mixed, and independent ones found little or no benefit.

    Human RCTIn clinical trialssleep / safety regulation
  • Elamipretide (SS-31)

    SS-31, SS31, MTP-131, Bendavia, Forzinity, RX-31, Ocuvia

    A synthetic mitochondrial tetrapeptide given FDA accelerated approval in 2025 for Barth syndrome only. No trial has tested it against ageing.

    Human RCTApproved for a medical indicationlongevity / safety regulation
  • Epitalon

    Epithalon, Epithalone, AEDG, Ala-Glu-Asp-Gly, AEDG peptide

    A four-amino-acid peptide studied almost only by one Russian network. No trial with a clinical outcome was found; its lifespan data are from animals.

    Case reportPreclinical onlylongevity / sleep / safety regulation
  • GHK-Cu

    copper tripeptide-1, GHK copper, prezatide copper, glycyl-L-histidyl-L-lysine copper

    A three-amino-acid peptide bound to copper, used in skin care. Its human studies are topical; none injected GHK-Cu on its own or tested it systemically.

    Human RCTIn clinical trialsskin hair / safety regulation
  • Ipamorelin

    NNC 26-0161, Ipamorelin acetate

    A synthetic growth hormone secretagogue. Never approved; its one published clinical trial, in postoperative ileus, did not show a benefit.

    Human RCTDevelopment discontinuedperformance / safety regulation
  • Melanotan II

    Melanotan 2, Melanotan-II, MT-II, MTII, MT2

    A synthetic cyclic peptide sold for tanning. Its human trials total 23 men between 1996 and 2000, and none of the regulators checked has approved it.

    Case reportIn clinical trialsskin hair / safety regulation
  • MOTS-c

    MOTs-c, MOTs-C, MOTSc, MOTS-C, Mitochondrial-derived peptide MOTS-c, Mitochondrial open reading frame of the 12S rRNA-c

    A 16-amino-acid peptide encoded in mitochondrial DNA. Its metabolic and lifespan data come from mice; no human trial of it has reported results.

    Human obs.Preclinical onlylongevity / safety regulation
  • Selank

    TKPRPGP, Thr-Lys-Pro-Arg-Pro-Gly-Pro, TP-7, Selank acetate

    A seven-amino-acid tuftsin analogue. Its patient studies are small, Russian and without placebo; FDA lists it as a withdrawn compounding nomination.

    Case reportIn clinical trialscognition / safety regulation
  • Semax

    Semaks, ACTH(4-7)-Pro-Gly-Pro, ACTH(4-7)PGP, MEHFPGP, Met-Glu-His-Phe-Pro-Gly-Pro

    A seven-amino-acid ACTH fragment analogue that FDA reports is registered in Russia. Its human studies are small, mostly Russian, and not placebo-randomised.

    Case reportIn clinical trialscognition / safety regulation

Further reading

Safety

Is selank legal? What regulators have said

No regulator document found approves selank. What FDA, Health Canada and New Zealand's Medsafe have said about selling, importing and holding it.

10 sources

Comparison

Semax vs Selank: what the evidence separates

Semax and Selank compared on what was measured: small Russian studies, no head-to-head clinical trial, one shared fMRI study and different FDA histories.

27 sources